MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk ; volume:17 ; number:1 ; day:3 ; month:2 ; year:2017 ; pages:1-6 ; date:12.2017
BMC cancer ; 17, Heft 1 (3.2.2017), 1-6, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Gansmo, Liv B.
- Beteiligte Personen und Organisationen
-
Bjørnslett, Merete
Halle, Mari Kyllesø
Salvesen, Helga B.
Romundstad, Pål
Hveem, Kristian
Vatten, Lars
Dørum, Anne
LøNning, Per E.
Knappskog, Stian
SpringerLink (Online service)
- DOI
-
10.1186/s12885-017-3094-y
- URN
-
urn:nbn:de:1111-201702281080
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
02.01.2025, 15:14 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gansmo, Liv B.
- Bjørnslett, Merete
- Halle, Mari Kyllesø
- Salvesen, Helga B.
- Romundstad, Pål
- Hveem, Kristian
- Vatten, Lars
- Dørum, Anne
- LøNning, Per E.
- Knappskog, Stian
- SpringerLink (Online service)
Ähnliche Objekte (12)
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
MDM2 negatively regulates the human telomerase RNA gene promoter
Gene Promoter Methylation in Endometrial Carcinogenesis
Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers
Identification of functional DNA variants in the constitutive promoter region of MDM2
AQP5-1364A/C polymorphism affects AQP5 promoter methylation
Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
DNA methylation profiles of ovarian cysts resemble ovarian tissues but not endometrial tissues
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
MDM2 negatively regulates the human telomerase RNA gene promoter
Gene Promoter Methylation in Endometrial Carcinogenesis
Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers
Identification of functional DNA variants in the constitutive promoter region of MDM2
AQP5-1364A/C polymorphism affects AQP5 promoter methylation
Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
DNA methylation profiles of ovarian cysts resemble ovarian tissues but not endometrial tissues
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
MDM2 negatively regulates the human telomerase RNA gene promoter
Gene Promoter Methylation in Endometrial Carcinogenesis
Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers
Identification of functional DNA variants in the constitutive promoter region of MDM2
AQP5-1364A/C polymorphism affects AQP5 promoter methylation
Ninjurin 2 rs118050317 gene polymorphism and endometrial cancer risk
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells